NASDAQ · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · SMALL CAP
Sensus Healthcare, Inc. SRTS
11 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$27.5M
▼ 34.3% vs FY2024
EPS · FY25
$-0.47
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-14.9%
Net margin · FY25
-28.1%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 27.5M
Revenue, FY2025 · full 11-year series below
Revenue
Net income
The company lost 28 cents on every revenue dollar this year.
Per share
USD -0.47
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-14.9%
Return on equity, FY2025
ROE
Operating margin-37.5%
Net margin-28.1%
Return on assets-13.4%
Each USD of equity lost 15 cents this year.
Returned to shareholders
USD 300,000.00
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 300,000.00
Share of profit-3.9%
Consecutive raises—
USD 300,000.00 in buybacks went back to shareholders in a year without profit.
Growth
+23.5% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−14.9%
+23.5%
+10.3%
Returned to shareholders
−49.0%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.02B
Shares outstanding, FY2025
Change, 5 years−0.2%
Change, 10 years+58.8%
The share count shrank 0% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 53.0M
total assets, end of FY2025
Total assetsUSD 53.0M
EquityUSD 48.1M
CashUSD 22.1M
Current ratio9.72×
Equity funds 91% of total assets.
History
11 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
Revenue $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Operating income $B
−0.0
0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EBITDA $B
−0.0
0.0
−0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
0.0
Income tax $B
−0.0
0.0
0.0
0.0
·
·
·
·
·
·
·
Net income $B
−0.0
0.0
0.0
0.0
0.0
−0.0
−0.0
−0.0
−0.0
−0.0
−0.0
EPS, diluted $
−0.47
0.41
0.03
1.46
0.25
−0.42
−0.10
−0.14
−0.28
−0.03
−0.08
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
ROE %
−14.9
12.7
1.0
65.5
17.3
−27.6
−6.2
−10.6
−27.5
−3.3
−4.0
Shares out B
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.01
0.01
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
44 of 44
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed